Last reviewed · How we verify
Butoconazole Nitrate Vaginal Cream
At a glance
| Generic name | Butoconazole Nitrate Vaginal Cream |
|---|---|
| Sponsor | Padagis LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Randomized Study Evaluating the Therapeutic Equivalence of Two Butoconazole Nitrate Vaginal Cream, 2% Formulations (NA)
- Efficacy and Safety of Different Doses of Venus Association in Patients With Vulvovaginal Candidiasis. (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Butoconazole Nitrate Vaginal Cream CI brief — competitive landscape report
- Butoconazole Nitrate Vaginal Cream updates RSS · CI watch RSS
- Padagis LLC portfolio CI